Julia C. Gage | |
---|---|
![]() Gage in 2019 | |
Alma mater |
Grinnell College Milken Institute School of Public Health Johns Hopkins Bloomberg School of Public Health |
Scientific career | |
Fields | Cancer epidemiology, cervical screening, HPV |
Institutions | National Cancer Institute |
Doctoral advisor | Janet Holbrook |
Julia C. Gage is an American cancer epidemiologist who researches cervical screening and the human papillomavirus infection. She is a staff scientist in the clinical genetics branch at the National Cancer Institute.
Gage completed a B.A. in political science with a concentration in Latin American studies from Grinnell College in 1995. [1] From October 1996 to August 1998, she worked for AFL–CIO as an Organizing Institute apprentice and later a union organizer for the Service Employees International Union. [1] Gage worked for the Maxwell Stamp, Inc. in Washington, D.C. as a business development and research assistant from September 1998 to March 2000. [1]
From March 2000 to February 2002, Gage was a research assistant and consultant in the non-communicable disease program of the Pan American Health Organization were she primarily used Spanish and designed study protocols. [1] In 2001, she earned a M.P.H. in international health promotion from the George Washington Milken Institute School of Public Health. [1] Between September 2002 to August 2004, Gage worked at the Health Resources and Services Administration, first as a scholar and then as a public health analyst in the office of data and information management in the Maternal and Child Health Bureau. [1]
In 2005, Gage joined the National Cancer Institute's (NCI) division of cancer epidemiology and genetics (DCEG) as a pre-doctoral fellow while pursuing a Ph.D. in epidemiology at the Johns Hopkins Bloomberg School of Public Health. [2] She completed her Ph.D. in epidemiology in 2008. Her dissertation was titled, An evaluation of visual triage of human papillomavirus-positive women. [1] Janet Holbrook was her doctoral advisor and Mark Schiffman of NCI was her mentor. [1] Gage completed a postdoctoral fellowship at the NCI, first in the hormonal and reproductive epidemiology branch, and then in the clinical genetics branch (CGB). [2]
Gage has worked as a staff scientist in the CGB since 2014. She works on projects with Nicolas Wentzensen, Philip E. Castle, and Schiffman. [2] Gage is focused on translating discoveries regarding the natural history of human papillomavirus (HPV) into improved screening and diagnosis for cervical precancer. [2] In particular, she investigates improved targeting of underlying precancer through HPV tests and biomarkers. [2] Gage also pursues scientific investigations to identify and bring new technologies for cervical cancer prevention to low medical resource settings. [2] Along with Wentzensen, Gage serves as co-investigator for multiple studies within the DCEG collaboration with Kaiser Permanente of Northern California (KPNC). [2] She is a co-investigator of the Improving Risk Informed HPV Screening (IRIS) Study, involving HPV and cytology specimens from over 77,000 participants. [2]
Under the leadership of Schiffman, Gage is part of a team of investigators at the NCI and the National Library of Medicine developing a simple, low-cost visual cervical screening method called automated visual evaluation (AVE). [2] She leads the development of a deep learning algorithm that will inform clinical management decisions when testing positive. [2] Gage serves as lead NCI investigator under the direction of Schiffman to evaluate the effectiveness and cost-effectiveness of cervical screening and triage strategies in the Management of Risk of Cervical Cancer (MARCO) project. [2] Under the supervision of Castle, division of cancer prevention, Gage is the lead NCI scientist for an NCI grant-funded cross-sectional study of HPV screening and triage strategies among 5,000 women living with HIV. She is also the lead NCI scientist on a second Rwandan study of the impact of prophylactic HPV vaccination on HPV immunity and HPV infection in women living with HIV. [2] Gage received the Hubert H. Humphrey Award for Service to America in 2022. [2]
Julia C. Gage | |
---|---|
![]() Gage in 2019 | |
Alma mater |
Grinnell College Milken Institute School of Public Health Johns Hopkins Bloomberg School of Public Health |
Scientific career | |
Fields | Cancer epidemiology, cervical screening, HPV |
Institutions | National Cancer Institute |
Doctoral advisor | Janet Holbrook |
Julia C. Gage is an American cancer epidemiologist who researches cervical screening and the human papillomavirus infection. She is a staff scientist in the clinical genetics branch at the National Cancer Institute.
Gage completed a B.A. in political science with a concentration in Latin American studies from Grinnell College in 1995. [1] From October 1996 to August 1998, she worked for AFL–CIO as an Organizing Institute apprentice and later a union organizer for the Service Employees International Union. [1] Gage worked for the Maxwell Stamp, Inc. in Washington, D.C. as a business development and research assistant from September 1998 to March 2000. [1]
From March 2000 to February 2002, Gage was a research assistant and consultant in the non-communicable disease program of the Pan American Health Organization were she primarily used Spanish and designed study protocols. [1] In 2001, she earned a M.P.H. in international health promotion from the George Washington Milken Institute School of Public Health. [1] Between September 2002 to August 2004, Gage worked at the Health Resources and Services Administration, first as a scholar and then as a public health analyst in the office of data and information management in the Maternal and Child Health Bureau. [1]
In 2005, Gage joined the National Cancer Institute's (NCI) division of cancer epidemiology and genetics (DCEG) as a pre-doctoral fellow while pursuing a Ph.D. in epidemiology at the Johns Hopkins Bloomberg School of Public Health. [2] She completed her Ph.D. in epidemiology in 2008. Her dissertation was titled, An evaluation of visual triage of human papillomavirus-positive women. [1] Janet Holbrook was her doctoral advisor and Mark Schiffman of NCI was her mentor. [1] Gage completed a postdoctoral fellowship at the NCI, first in the hormonal and reproductive epidemiology branch, and then in the clinical genetics branch (CGB). [2]
Gage has worked as a staff scientist in the CGB since 2014. She works on projects with Nicolas Wentzensen, Philip E. Castle, and Schiffman. [2] Gage is focused on translating discoveries regarding the natural history of human papillomavirus (HPV) into improved screening and diagnosis for cervical precancer. [2] In particular, she investigates improved targeting of underlying precancer through HPV tests and biomarkers. [2] Gage also pursues scientific investigations to identify and bring new technologies for cervical cancer prevention to low medical resource settings. [2] Along with Wentzensen, Gage serves as co-investigator for multiple studies within the DCEG collaboration with Kaiser Permanente of Northern California (KPNC). [2] She is a co-investigator of the Improving Risk Informed HPV Screening (IRIS) Study, involving HPV and cytology specimens from over 77,000 participants. [2]
Under the leadership of Schiffman, Gage is part of a team of investigators at the NCI and the National Library of Medicine developing a simple, low-cost visual cervical screening method called automated visual evaluation (AVE). [2] She leads the development of a deep learning algorithm that will inform clinical management decisions when testing positive. [2] Gage serves as lead NCI investigator under the direction of Schiffman to evaluate the effectiveness and cost-effectiveness of cervical screening and triage strategies in the Management of Risk of Cervical Cancer (MARCO) project. [2] Under the supervision of Castle, division of cancer prevention, Gage is the lead NCI scientist for an NCI grant-funded cross-sectional study of HPV screening and triage strategies among 5,000 women living with HIV. She is also the lead NCI scientist on a second Rwandan study of the impact of prophylactic HPV vaccination on HPV immunity and HPV infection in women living with HIV. [2] Gage received the Hubert H. Humphrey Award for Service to America in 2022. [2]